Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

May 31, 2008

Conditions
Multiple Sclerosis
Interventions
DRUG

Fampridine-SR

Tablets, 10 mg, twice daily, 9 weeks

DRUG

Placebo

placebo (sugar pill)

Trial Locations (40)

10029

Corinne Goldsmith Dickinson Center for MS, New York

10032

Columbia University Multiple Sclerosis Clinical Care Center, New York

11794

SUNY Stony Brook, Stony Brook

14203

Jacobs Neurological Institute Buffalo General Hospital, Buffalo

14642

University of Rochester, Rochester

19107

Thomas Jefferson University Physicians, Philadelphia

21201

Maryland Center for MS, Baltimore

25304

CAMC Health Education & Research Institute, Charleston

27157

Wake Forest University, Dept of Neurology, M.S. Research, Winston-Salem

27607

Raleigh Neurology Associates, Raleigh

28207

CMC - Neuroscience & Spine Institute, Division of Neurology, Charlotte

30309

Shepherd Center, Atlanta

40503

Associates in Neurology, PSC, Lexington

43221

Ohio State University MS Center, Columbus

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University MS Center, Indianapolis

53215

Center for Neurological Disorders of Aurora, St. Luke's Medical Center, Milwaukee

55422

The Schapiro Center for MS, Golden Valley

58501

The Center for Neurological Services, Bismarck

59405

Advanced Neurology Specialists, Great Falls

60062

Consultants in Neurology, Ltd., Northbrook

63110

Washington University School of Medicine, St Louis

72703

Neurological Associates, Fayetteville

85013

Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center, Phoenix

85050

HOPE Research Institute, Phoenix

90033

USC, Keck School of Medicine Health Care Consultation Center, Los Angeles

94705

Alta Bates Summit Medical Center - Research and Education Institute, Berkeley

95817

UC Davis, Sacramento

97239

Oregon Health & Science University, MS Center of Oregon, UHS-42, Portland

98034

MS Center at Evergreen, Kirkland

06510

Yale University MS Center, New Haven

02421

Lahey Clinic, Lexington

07103

UMDNJ, Newark

07666

Gimbel MS Center at Holy Name Hospital, Teaneck

05201

Neurological Research Center, Inc., Bennington

05401

Fletcher Allen Health Care, Burlington

T2N 2T9

Foothills Medical Center, Calgary

V6T 2B5

University of British Columbia, Vancouver Coastal Health Research Institute, Vancouver

E3B 0C7

River Valley Health c/o Stan Cassidy Centre for Rehabilitation, Fredericton

B3H 4K4

QEII Health Sciences Centre, Nova Scotia Rehabilitation Centre Site, Halifax

Sponsors
All Listed Sponsors
lead

Acorda Therapeutics

INDUSTRY